Neurostimulation Devices Market Analysis Report | Size & Share 2030
[Research Report] The neurostimulation devices market is expected to grow from US$ 5,802.47 million in 2022 and is expected to reach US$ 11,825.95 million by 2030; it is anticipated to record a CAGR of 9.3% from 2022 to 2030.
Market Insights and Analyst View:
Neurostimulation devices are medical devices designed to modulate the nervous system's activity. They are used to treat various neurological conditions and chronic pain. There are several types of neurostimulation devices, including spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, and peripheral nerve stimulators. These devices can significantly improve the quality of life for individuals with various neurological conditions. The increasing prevalence of neurological diseases and increasing spinal cord injury cases are the key factors behind the market development. However, the lack of expert professionals is hampering the neurostimulation devices market growth.
Growth Drivers and Challenges:
The geriatric population is susceptible to neurological diseases. Common neurological disorders affecting older people are neuropathy, Parkinson's disease, Alzheimer's disease, dystonia, and others. According to the National Institutes of Health (NIH), 8.5% of the world's population (i.e., ~617 million people) is 65 years and above. Countries such as the US and Canada have high prevalence rates of movement disorders and psychiatric disorders associated with growing geriatric populations. According to the Parkinson's Foundation, Parkinson's symptoms are common at an average age of 60.
The Canadian Psychological Association states that obsessive-compulsive disorder (OCD) affects ~2% of the population in Canada. The World Health Organization (WHO) states that epilepsy is a seizure-causing neurological disorder that affects ~50 million people worldwide. As per the American Academy of Neurology, stroke is the third leading cause of death in the US, followed by Alzheimer's as the sixth leading cause. Statistics from the same source show that nearly one million Americans are affected by Parkinson's, and at least 60,000 new cases are reported annually. The growing incidence of neurological diseases coupled with lifestyle-related disorders such as depression and chronic pain leads to the increasing adoption of technologically advanced products.
According to the WHO, nervous disorders contribute to ~6.3% of the global disease burden. Also, according to the same source, the disorders are one of the leading causes of death worldwide. They cause 13.2% of deaths in developed countries and 16.8% in low- and middle-income countries. High mortality and disease burden necessitate the clinical urgency for integrating long-term solutions. Furthermore, growing awareness regarding the tremendous burden of neurological disorders has increased the demand for neurostimulators as a therapy.
Therefore, the growing geriatric population prone to neurological diseases, increasing prevalence of the diseases, and rising awareness regarding the tremendous burden of neurological disorders drive the neurostimulation devices market size.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Neurostimulation Devices Market: Strategic Insights
Market Size Value in US$ 5,802.47 million in 2022 Market Size Value by US$ 11,825.95 million by 2030 Growth rate CAGR of 9.3% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Neurostimulation Devices Market: Strategic Insights
| Market Size Value in | US$ 5,802.47 million in 2022 |
| Market Size Value by | US$ 11,825.95 million by 2030 |
| Growth rate | CAGR of 9.3% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The global neurostimulation devices market is segmented on the basis of product, application, and end user. Based on the product, the market is segmented into spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, and vagus nerve stimulators. In terms of application, the neurostimulation devices market is segmented into pain management, epilepsy, urinary and fecal incontinence, Parkinson’s disease, and others. The neurostimulation devices market, by end user, is segmented into hospitals, specialty clinics, and others. The neurostimulation devices market, based on geography, is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Russia, and the Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Segmental Analysis:
Based on product, the neurostimulation devices market is segmented into spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. The spinal cord stimulator segment held the largest market share in 2022 and is anticipated to register a higher CAGR during 2022–2030. Spinal cord stimulation can treat patients with severe, chronic pain due to various conditions, including failed back surgery/arachnoiditis, neuropathic pain/neuropathy, and complex regional pain syndrome/reflex sympathetic dystrophy. A few SCS devices use a low-frequency current to change the pain sensation with a mild tingling called paresthesia. Other SCS devices use high-frequency or burst pulses to mask the pain without a tingling sensation.
Spinal cord stimulation has become a basic in interventional pain management to treat various chronic pain conditions. Advances have been made since its initial inception in 1967, leading to new technologies allowing for minimally invasive placement and internalized batteries. For instance, in May 2023, Abbott received approval from the U.S. Food and Drug Administration (FDA) for SCS devices for treating chronic back pain in people not able to receive back surgery, known as nonsurgical back pain. Furthermore, in August 2023, Medtronic plc received CE Mark approval for its Inceptiv closed-loop rechargeable SCS. It is the first Medtronic SCS device to offer a closed-loop feature that senses each person's unique biological signals and adjusts stimulation every moment, as needed, to keep therapy in harmony with the motions of daily life. Such developments are boosting the adoption of SCS, fueling the segment growth in the global neurostimulation devices market.
The neurostimulation devices market, by application, is segmented into pain management, epilepsy, urinary and fecal incontinence, Parkinson’s disease, and others. The pain management segment held the largest market share in 2022, and the same is anticipated to register a higher CAGR during 2022–2030.
Chronic pain affects geriatric people, trauma and surgery patients, people undergoing different therapies, and those linked to various physical and mental conditions. As per the US Centers for Disease Control and Prevention (CDC), back pain is the second leading reason for hospital visits, and ~60% and 80% of people experience lower back pain during their lifetime, which is one of the major reasons for hospital admission or surgeries.
Neurostimulation is a safer and more efficient solution for alleviating chronic pain and is widely adopted. Numerous biotech companies are launching neurostimulators to help opioid addicts overcome pain and other withdrawal symptoms. For example, in April 2021, Spark Biomedical, a leading medical device company, rolled out a new neurostimulation device called Sparrow Therapy System to help opioid addicts work through withdrawal symptoms. The device uses low doses of electricity to stimulate endorphin production, which helps to alleviate the pain and fear that patients experience during withdrawal. Furthermore, in March 2021, Mainstay Medical launched ReActiv8, an implantable neurostimulation device for chronic low back pain (CLBP), in Australia. The device can potentially be helpful to adults with intractable CLBP linked with the dysfunction of the lumbar multifidus. In January 2023, the FDA approved Abbott’s Proclaim X.R. spinal cord neurostimulation system, which supports patients with diabetic peripheral neuropathy to manage chronic pain. Thus, the application and benefits mentioned above positively influence the neurostimulation devices market during 2022–2030.
Regional Analysis:
Based on geography, the neurostimulation devices market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. The market in North America has been analyzed with a prime focus on three major countries—the US, Canada, and Mexico. The US held the largest share of the North America neurostimulation devices market in 2022. It is estimated to hold the largest share of the neurostimulation devices market in North America during the forecast period owing to the growing prevalence of neurological diseases, high spending on research and development, product approvals by the U.S. Food and Drug Administration (FDA), and technological advances. In the U.S., the incidence of neurovascular diseases is rising significantly and is becoming the leading cause of death. Rising incidence of neurological diseases such as Parkinson's disease (P.D.), increasing awareness about neurological disorders, and growing investments in developing transcranial stimulators are among the main factors driving the overall neurostimulation devices market in the US. Deep brain stimulation (DBS) devices have been observed to control the tremors associated with Parkinson's disease effectively. Low dopamine readings and other genetic factors are among the leading causes of Parkinson's disease. According to a study titled "2022 Alzheimer's Disease Facts and Figures," published in the Alzheimer's Association, nearly 6.5 million Americans aged 65 and above were diagnosed with Alzheimer's disease in 2022. That number is projected to rise to 13.8 million by 2060. According to the Parkinson's Foundation, the number of people to suffer from Parkinson’s disease in the US was expected to increase to 1.2 million by 2030. Technological advancements and new product launches drive the neurostimulation devices market. In January 2020, Abbott's neurostimulator Infinity DBS System received approval from the USFDA for treating Parkinson's disease. This system allows for the targeted treatment of a specific area of the brain, called the inner globus pallidus (GPi), which is associated with the symptoms of Parkinson's disease. Therefore, the increasing prevalence of neurological disorders and technological advancements fuel the neurostimulation devices market growth in the US.
Competitive Landscape and Key Companies:
Neurostimulation device market developments have been characterized as organic and inorganic growth strategies. Various companies focus on organic growth strategies such as product launches, expansion, enhancement, and relocation. Inorganic growth strategies in the market are mergers and acquisitions, partnerships, and collaborations. These activities have paved the way for the expansion of businesses and customer base of neurostimulation devices market players.
- In August 2023, Mainstay Medical Holdings plc announced the completion of enrollment in its RESTORE randomized clinical study of ReActiv8 for the treatment of intractable chronic low back pain. The study is designed to provide a direct comparison to optimized medical management to test the hypothesis that adding ReActiv8 Restorative Neurostimulation therapy to current care paradigms significantly improves back pain-related disability.
- In April 2023, Synapse Biomedical, Inc. announced the FDA approval (PMA) of the NeuRx Diaphragm Pacing System (NeuRx DPS) for use in patients suffering from spinal cord injuries who rely on mechanical ventilation. PMA is the most stringent type of device marketing application required by the FDA.
- In August 2023, Abbott announced the U.S. Food and Drug Administration (FDA) approved its new Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360 therapy. The next generation of Abbott's proprietary BurstDR stimulation, FlexBurst360 therapy, offers pain coverage across six areas of the trunk and/or limbs. It enables programming that can be adjusted as a person's therapeutic needs evolve.
- In May 2023, Abbott announced the U.S. Food and Drug Administration (FDA) approval of its spinal cord stimulation (SCS) devices for treating chronic back pain in people who have not had or are not eligible to receive back surgery, known as nonsurgical back pain.
- In January 2021, Medtronic plc received U.S. Food and Drug Administration (FDA) approval for Vanta, a high-performance recharge-free implantable neurostimulator (INS) with a device life that can be optimized up to 11 years. The Vanta neurostimulator offers nearly twice the device life at comparable settings than competitive primary cell devices.
- In January 2022, Medtronic plc received approval from the U.S. Food and Drug Administration for its Intellis rechargeable neurostimulator and Vanta recharge-free neurostimulator for treating chronic pain associated with diabetic peripheral neuropathy (DPN).
Neurostimulation Devices Market Report Scope
Company Profiles
- Medtronic Plc
- Boston Scientific Corp
- Abbott Laboratories
- Nevro Corp
- LivaNova Plc
- Synapse Biomedical Inc
- Nalu Medical, Inc
- ElectroCore Inc
- MicroTransponder Inc
- Mainstay Medical
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Application, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The factors that are driving the market is the growing prevalence of neurological diseases and increasing cases of spinal cord injury are the key driving factors behind the market development. However, lack of expert professionals is hampering the market growth.
The neurostimulation devices market majorly consists of the players such Medtronic Plc, Boston Scientific Corp; Abbott Laboratories, Nevro Corp; LivaNova Plc, Synapse Biomedical Inc, Nalu Medical, Inc, ElectroCore Inc; MicroTransponder Inc, and Mainstay Medical among others.
The neurostimulation devices market is analyzed in the product, application, and end user. The market based on product, is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held a larger market share in 2022 and the same is anticipated to register a higher CAGR during the 2022-2030. The neurostimulation devices market, by application, is segmented into pain management, epilepsy, urinary and fecal incontinence, Parkinson’s disease, and others. The pain management segment held a larger market share in 2022 and the same is anticipated to register a higher CAGR during the 2022-2030. The neurostimulation devices market, by end user, is bifurcated into hospitals, specialty clinics, and others. The hospitals segment held the largest share of the market in 2022 and specialty clinics segment is anticipated to register the highest CAGR in the market during 2022-2030.
Neurostimulation devices are medical devices designed to modulate the activity of the nervous system. They are used to treat various neurological conditions and chronic pain. There are several types of neurostimulation devices, including spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, peripheral nerve stimulator. These devices have the potential to significantly improve the quality of life for individuals with various neurological conditions.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Neurostimulation Devices Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Neurostimulation Devices Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Neurostimulation Devices Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Neurological Disorders
5.1.2 Rising Cases of Spinal Cord Injury
5.2 Market Restraints
5.2.1 Lack of Expert Professionals
5.3 Market Opportunities
5.3.1 Growing Advances and Approvals for Neurostimulation Devices
5.4 Future Trends
5.4.1 Rising Demand for Noninvasive Treatment
5.5 Impact Analysis
6. Neurostimulation Devices Market - Global Market Analysis
6.1 Neurostimulation Devices Market Revenue (US$ Mn), 2022 – 2030
7. Global Neurostimulation Devices Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Spinal Cord Stimulator
7.3.1 Overview
7.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Deep Brain Stimulator
7.4.1 Overview
7.4.2 Deep Brain Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Sacral Nerve Stimulator
7.5.1 Overview
7.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Vagus Nerve Stimulator
7.6.1 Overview
7.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Neurostimulation Devices Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Pain Management
8.3.1 Overview
8.3.2 Pain Management: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Epilepsy
8.4.1 Overview
8.4.2 Epilepsy: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Urinary and Fecal Incontinence
8.5.1 Overview
8.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Parkinson’s Disease
8.6.1 Overview
8.6.2 Parkinson’s Disease: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Neurostimulation Devices Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Specialty Clinics
9.4.1 Overview
9.4.2 Specialty Clinics: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10. Neurostimulation Devices Market – Revenue and Forecast to 2030 – Geographic Analysis
10.1 North America: Neurostimulation Devices Market
10.1.1 Overview
10.1.2 North America: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1 North America: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.1.2.2 North America: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.1.2.3 North America: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.1.3 North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
10.1.3.1 US: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.1.3.2 US: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.2.1 US: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.1.3.2.2 US: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.1.3.2.3 US: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.1.3.3 Canada: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.1.3.4 Canada: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.4.1 Canada: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.1.3.4.2 Canada: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.1.3.4.3 Canada: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.1.3.5 Mexico: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.1.3.6 Mexico: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.6.1 Mexico: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.1.3.6.2 Mexico: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.1.3.6.3 Mexico: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.2 Europe: Neurostimulation Devices Market
10.2.1 Overview
10.2.2 Europe: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.2.2.1 Europe: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.2.2.2 Europe: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.2.2.3 Europe: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.2.3 Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
10.2.3.1 Germany: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.2 Germany: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.2.1 Germany: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.2.3.2.2 Germany: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.2.3.2.3 Germany: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.2.3.3 UK: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.4 UK: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.4.1 UK: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.2.3.4.2 UK: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.2.3.4.3 UK: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.2.3.5 France: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.6 France: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.6.1 France: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.2.3.6.2 France: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.2.3.6.3 France: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.2.3.7 Italy: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.8 Italy: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.8.1 Italy: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.2.3.8.2 Italy: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.2.3.8.3 Italy: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.2.3.9 Spain: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.10 Spain: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.10.1 Spain: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.2.3.10.2 Spain: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.2.3.10.3 Spain: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.2.3.11 Rest of Europe: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.12 Rest of Europe: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.12.1 Rest of Europe: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.2.3.12.2 Rest of Europe: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.2.3.12.3 Rest of Europe: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.3 Asia Pacific: Neurostimulation Devices Market
10.3.1 Overview
10.3.2 Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
10.3.2.1 Asia Pacific: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.3.2.2 Asia Pacific: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.3.2.3 Asia Pacific: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.3.3 Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
10.3.3.1 China: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.2 China: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.2.1 China: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.3.3.2.2 China: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.3.3.2.3 China: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.3.3.3 Japan: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.4 Japan: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.4.1 Japan: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.3.3.4.2 Japan: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.3.3.4.3 Japan: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.3.3.5 India: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.6 India: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.6.1 India: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.3.3.6.2 India: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.3.3.6.3 India: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.3.3.7 Australia: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.8 Australia: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.8.1 Australia: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.3.3.8.2 Australia: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.3.3.8.3 Australia: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.3.3.9 South Korea: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.10 South Korea: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.10.1 South Korea: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.3.3.10.2 South Korea: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.3.3.10.3 South Korea: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.3.3.11 Rest of Asia Pacific: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.12 Rest of Asia Pacific: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.12.1 Rest of Asia Pacific: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.3.3.12.2 Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.3.3.12.3 Rest of Asia Pacific: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.4 Middle East & Africa Neurostimulation Devices Market
10.4.1 Overview
10.4.2 Middle East & Africa: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.4.2.1 Middle East & Africa: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.4.2.2 Middle East & Africa: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.4.2.3 Middle East & Africa: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.4.3 Middle East & Africa: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
10.4.3.1 Saudi Arabia: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.2 Saudi Arabia: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.2.1 Saudi Arabia: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.4.3.2.2 Saudi Arabia: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.4.3.2.3 Saudi Arabia: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.4.3.3 South Africa: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.4 South Africa: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.4.1 South Africa: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.4.3.4.2 South Africa: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.4.3.4.3 South Africa: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.4.3.5 UAE: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.6 UAE: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.6.1 UAE: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.4.3.6.2 UAE: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.4.3.6.3 UAE: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.4.3.7 Rest of Middle East & Africa: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.8 Rest of Middle East & Africa: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.8.1 Rest of Middle East & Africa: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.4.3.8.2 Rest of Middle East & Africa: Neurostimulation Devices Market, by Application, 2020–2030 (US$ Million)
10.4.3.8.3 Rest of Middle East & Africa: Neurostimulation Devices Market, by End User, 2020–2030 (US$ Million)
10.5 South & Central America: Neurostimulation Devices Market
10.5.1 Overview
10.5.2 South & Central America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
10.5.2.1 South & Central America: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.5.2.2 South & Central America: Neurostimulation Devices Market, By Application, 2020–2030 (US$ Million)
10.5.2.3 South & Central America: Neurostimulation Devices Market, By End User, 2020–2030 (US$ Million)
10.5.3 South & Central America: Neurostimulation Devices Market Share by Country – 2022 & 2030, (%)
10.5.3.1 Brazil: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.5.3.2 Brazil: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.2.1 Brazil: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.5.3.2.2 Brazil: Neurostimulation Devices Market, By Application, 2020–2030 (US$ Million)
10.5.3.2.3 Brazil: Neurostimulation Devices Market, By End User, 2020–2030 (US$ Million)
10.5.3.3 Argentina: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.5.3.4 Argentina: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.4.1 Argentina: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.5.3.4.2 Argentina: Neurostimulation Devices Market, By Application, 2020–2030 (US$ Million)
10.5.3.4.3 Argentina: Neurostimulation Devices Market, By End User, 2020–2030 (US$ Million)
10.5.3.5 Rest of South & Central America: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
10.5.3.6 Rest of South & Central America: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.6.1 Rest of South & Central America: Neurostimulation Devices Market, by Product, 2020–2030 (US$ Million)
10.5.3.6.2 Rest of South & Central America: Neurostimulation Devices Market, By Application, 2020–2030 (US$ Million)
10.5.3.6.3 Rest of South & Central America: Neurostimulation Devices Market, By End User, 2020–2030 (US$ Million)
11. Neurostimulation Devices Market–Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Medtronic Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Boston Scientific Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Abbott Laboratories
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Nevro Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 LivaNova Plc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Synapse Biomedical Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Nalu Medical, Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 ElectroCore Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MicroTransponder Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Mainstay Medical
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. Neurostimulation Devices Market Segmentation
Table 2. North America Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 5. US Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 6. US Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. US Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 11. Mexico Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Europe Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 15. Europe Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 16. Europe Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 17. Germany Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 18. Germany Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 19. Germany Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 20. UK Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 21. UK Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 22. UK Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 23. France Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 24. France Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 25. France Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 26. Italy Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 27. Italy Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 28. Italy Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 29. Spain Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 30. Spain Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 31. Spain Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Europe Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 33. Rest of Europe Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Europe Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 35. Asia Pacific Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 36. Asia Pacific Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 37. Asia Pacific Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 38. China Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 39. China Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 40. China Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 41. Japan Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 42. Japan Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 43. Japan Neurostimulation Devices Market, by End User– Revenue and Forecast to 2030 (US$ Million)
Table 44. India Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 45. India Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 46. India Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 47. Australia Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 48. Australia Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 49. Australia Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 50. South Korea Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 51. South Korea Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 52. South Korea Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 53. Rest of Asia Pacific Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 54. Rest of Asia Pacific Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 55. Rest of Asia Pacific Neurostimulation Devices Market, by End User– Revenue and Forecast to 2030 (US$ Million)
Table 56. Middle East & Africa Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 57. Middle East & Africa Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 58. Middle East & Africa Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 59. Saudi Arabia Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 60. Saudi Arabia Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 61. Saudi Arabia Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 62. South Africa Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 63. South Africa Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 64. South Africa Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 65. UAE Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 66. UAE Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 67. UAE Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 68. Rest of Middle East & Africa Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 69. Rest of Middle East & Africa Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 70. Rest of Middle East & Africa Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 71. South & Central America Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 72. South & Central America: Neurostimulation Devices Market, By Application – Revenue and Forecast to 2030 (US$ Million)
Table 73. South & Central America: Neurostimulation Devices Market, By End User – Revenue and Forecast to 2030 (US$ Million)
Table 74. Brazil Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 75. Brazil: Neurostimulation Devices Market, By Application – Revenue and Forecast to 2030 (US$ Million)
Table 76. Brazil: Neurostimulation Devices Market, By End User – Revenue and Forecast to 2030 (US$ Million)
Table 77. Argentina Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 78. Argentina: Neurostimulation Devices Market, By Application – Revenue and Forecast to 2030 (US$ Million)
Table 79. Argentina: Neurostimulation Devices Market, By End User – Revenue and Forecast to 2030 (US$ Million)
Table 80. Rest of South & Central Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 81. Rest of South & Central America: Neurostimulation Devices Market, By Application – Revenue and Forecast to 2030 (US$ Million)
Table 82. Rest of South & Central America: Neurostimulation Devices Market, By End User – Revenue and Forecast to 2030 (US$ Million)
Table 83. Organic Developments Done by Companies
Table 84. Inorganic Developments Done by Companies
Table 85. Glossary of Terms, Neurostimulation Devices Market
List of Figures
Figure 1. Neurostimulation Devices Market Segmentation, By Geography
Figure 2. Global - PEST Analysis
Figure 3. Neurostimulation Devices Market: Key Industry Dynamics
Figure 4. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints
Figure 5. Neurostimulation Devices Market Revenue (US$ Mn), 2020 – 2030
Figure 6. Global Neurostimulation Devices Market, By Geography Forecast Analysis, 2022 & 2030
Figure 7. Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
Figure 8. Spinal Cord Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Deep Brain Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Sacral Nerve Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Vagus Nerve Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
Figure 14. Pain Management: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Epilepsy: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Urinary and Fecal Incontinence: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Parkinson’s Disease: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
Figure 20. Hospitals & Clinics: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America: Neurostimulation Devices Market, by Key Country – Revenue (2022) (US$ Million)
Figure 24. North America Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 26. US: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Canada: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Mexico: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Europe: Neurostimulation Devices Market, by Key Country – Revenue (2022) (US$ Million)
Figure 30. Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 32. Germany: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. UK: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. France: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Italy: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. Spain: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. Rest of Europe: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 38. Asia Pacific: Neurostimulation Devices Market, by Key Country – Revenue (2022) (US$ Million)
Figure 39. Asia Pacific Neurostimulation Devices Market Revenue and Forecast to 2030 (US$ Million)
Figure 40. Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 41. China: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 42. Japan: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 43. India: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 44. Australia: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 45. South Korea: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 46. Rest of Asia Pacific: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 47. Middle East & Africa: Neurostimulation Devices Market, by Key Country – Revenue (2022) (US$ Million)
Figure 48. Middle East & Africa Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 49. Middle East & Africa: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 50. Saudi Arabia: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 51. South Africa: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 52. UAE: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 53. Rest of Middle East & Africa: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 54. South & Central America: Neurostimulation Devices Market, By Key Country – Revenue (2022) (US$ Million)
Figure 55. South & Central America: Neurostimulation Devices Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 56. South & Central America: Neurostimulation Devices Market Share by Country – 2022 & 2030, (%)
Figure 57. Brazil: Neurostimulation Devices Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 58. Argentina: Neurostimulation Devices Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 59. Rest of South & Central America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
The List of Companies - Neurostimulation Devices Market
- Medtronic Plc
- Boston Scientific Corp
- Abbott Laboratories
- Nevro Corp
- LivaNova Plc
- Synapse Biomedical Inc
- Nalu Medical, Inc
- ElectroCore Inc
- MicroTransponder Inc
- Mainstay Medical
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For